NCT00511875View on ClinicalTrials.gov

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Diabetic Retinopathy
Interventions
DRUG

doxycycline monohydrate

50mg once daily for 24 months

DRUG

placebo

placebo taken once daily for 24 months

Trial Locations (1)

17033

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Thomas Gardner

OTHER